R&D News | pharmaphorum

News

BI drug named Promising Innovative Medicine in mesothelioma

Boehringer Ingelheim is the latest company to gain a Promising Innovative Medicine (PIM) status in the UK for one of its drugs.

News

Novartis taking aim at Pfizer with new use for breast cancer...

FDA grants Breakthrough Therapy for Kisqali in premenopausal women.

News

PEAR raises $50m to develop digital therapeutics business

PEAR Therapeutics has raised $50m in a new financing round to fund development of its prescription digital therapeutics business.

News

Janssen's depression drug shows promise in phase 2

Ketamine may be best known as an anaesthetic illegally used as a party drug, but Janssen has shown that it could also be reformulated and used as a treatment for depression.

News

NICE to reassess Pfizer blood cancer drug

Company successfully appealed against rejection last summer

BI drug named Promising Innovative Medicine in mesothelioma

Novartis taking aim at Pfizer with new use for breast cancer...

PEAR raises $50m to develop digital therapeutics business

Janssen's depression drug shows promise in phase 2

NICE to reassess Pfizer blood cancer drug

Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer

Discover a new era of healthcare panel engagement: Grounded ...

News

Editor's Picks